ARSG
protein-codingarylsulfatase G, the group of Sulfatases
Gene summary
The protein encoded by this gene belongs to the sulfatase enzyme family. Sulfatases hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules. This protein displays arylsulfatase activity at acidic pH, as is typical of lysosomal sulfatases, and has been shown to localize in the lysosomes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~163.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0029141
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0016485
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0029141
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0029141
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0029141
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0029141
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The onset of hearing loss has been described as postlingual
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ARSG variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001267727.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 116 | 3 | 122 | ||
| missense | 2 | 6 | 191 | 14 | 2 | 215 |
| nonsense | 8 | 4 | 12 | |||
| start loss | 0 | |||||
| frameshift | 8 | 5 | 6 | 19 | ||
| splice donor/acceptor (+/-2bp) | 6 | 13 | 1 | 20 | ||
| Total | 24 | 28 | 201 | 130 | 5 | 388 |
Highest pathogenic variant AF is 0.00017781093
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001254656.1 | 11 | MANE Select | |
| Ensembl | ENSP00000480910.1 | 11 | MANE Select | |
| RefSeq | NP_001339828.1 | 11 | Standard | |
| RefSeq | NP_001339829.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysosome - Homo sapiens (human)
- Metabolism of lipids
- Post-translational protein modification
- Metabolism of proteins
- The activation of arylsulfatases
Biological Process
- sulfur compound metabolic process
Molecular Function
- arylsulfatase activity
- metal ion binding
Cellular Component
- extracellular space
- lysosome
- endoplasmic reticulum
- endoplasmic reticulum lumen
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000448504
- Coding exons
- 11
- Length
- 163550
- Individuals with no LoFs
- 125658
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 90
- Defined
- 125748
- p
- 0.000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.893 | 274 | 319 | 0.859 | 0.0000185 | 3399 |
| Missense (PolyPhen) | 96 | 121.71 | 0.78873 | 1236 | ||
| Synonymous | 0.786 | 115 | 126 | 0.911 | 0.00000809 | 1069 |
| Loss of Function | 1.03 | 17 | 22.2 | 0.765 | 9.43e-7 | 258 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00040 | 0.00040 | rare |
| South Asian | 0.00046 | 0.00046 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Displays arylsulfatase activity at acidic pH with pseudosubstrates, such as p-nitrocatechol sulfate and also, but with lower activity, p-nitrophenyl sulfate and 4- methylumbelliferyl sulfate. {ECO:0000269|PubMed:18283100}.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- LoFtool
- 0.171
- RVIS EVS
- 0.31
- RVIS percentile EVS
- 72.75
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.443
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | High |